Commonwealth Equity Services’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Commonwealth Equity Services’s Portfolio SEEL Stock Details SEEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7	Closed	-$5K	–	4044
2023 Q3	$5K	Hold	7	–	–	﹤0.01%	3803
2023 Q2	$32K	Sell	7 -1	-13%	-$3.47K	﹤0.01%	3715
2023 Q1	$20	Hold	8	–	–	﹤0.01%	3671
2022 Q4	$19K	Hold	8	–	–	﹤0.01%	3602
2022 Q3	$30K	Buy	8 +1	+14%	+$3.93K	﹤0.01%	3538
2022 Q2	$18K	Hold	7	–	–	﹤0.01%	3580
2022 Q1	$22K	Hold	7	–	–	﹤0.01%	3653
2021 Q4	$42K	Buy	7 +1	+17%	+$7.68K	﹤0.01%	3553
2021 Q3	$58K	Buy	6 +1	+20%	+$8.59K	﹤0.01%	3486
2021 Q2	$51K	Hold	5	–	–	﹤0.01%	3458
2021 Q1	$92K	Buy	+5	New	+$58.4K	﹤0.01%	3276

Other funds holding SEEL

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GJL

Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return

MWM

Modera Wealth Management Westwood, New Jersey $8.34B AUM 19.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Commonwealth Equity Services's SEEL Position: Q4 2023 in Review

Commonwealth Equity Services sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q4 2023, closing a stake of 7 shares — an estimated $5K sold.

Commonwealth Equity Services first reported a position in SEEL in Q1 2021 and held it in 11 quarters. The position peaked at $92K in Q1 2021. 32 funds tracked by Wall St. Rank hold SEEL as of Q4 2023.

Commonwealth Equity Services reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Commonwealth Equity Services sold 7 Seelos Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $5K.
Commonwealth Equity Services first reported a position in Seelos Therapeutics, Inc. Common Stock in Q1 2021 and held it in 11 quarters.
Commonwealth Equity Services's Seelos Therapeutics, Inc. Common Stock position peaked at $92K in Q1 2021.
32 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Commonwealth Equity Services's 13F filing for Q4 2023, filed 6 Feb 2024.